118 related articles for article (PubMed ID: 37599142)
1. County-level correlates of completed HPV vaccination in Indiana.
Enujioke SC; Shedd-Steele R; Daggy J; Burney HN; Head KJ; Kasting ML; Zimet G
Vaccine; 2023 Sep; 41(39):5752-5757. PubMed ID: 37599142
[TBL] [Abstract][Full Text] [Related]
2. County-level correlates of missed opportunities for HPV vaccination in Indiana: An environmental scan.
Enujioke SC; Shedd-Steele R; Daggy J; Burney H; Robertson L; Head K; Zimet G
Vaccine; 2020 Oct; 38(43):6730-6734. PubMed ID: 32891476
[TBL] [Abstract][Full Text] [Related]
3. Regional variation in human papillomavirus vaccination uptake and completion among adolescents 13-17 in the state of Texas.
Conrey R; Valencia V; Cioletti A; Williams-Brown MY
Vaccine; 2020 May; 38(25):4119-4124. PubMed ID: 32349907
[TBL] [Abstract][Full Text] [Related]
4. Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States.
Henry KA; Swiecki-Sikora AL; Stroup AM; Warner EL; Kepka D
BMC Public Health; 2017 Jul; 18(1):19. PubMed ID: 28709420
[TBL] [Abstract][Full Text] [Related]
5. Quality Improvement Project to Increase Human Papillomavirus Two-Dose Vaccine Series Completion by 13 Years in Pediatric Primary Care Clinics.
Smajlovic A; Toth CD
J Adolesc Health; 2023 Jun; 72(6):958-963. PubMed ID: 36925411
[TBL] [Abstract][Full Text] [Related]
6. County-level trends in vaccination coverage among children aged 19-35 months - United States, 1995-2008.
Smith PJ; Singleton JA; ;
MMWR Surveill Summ; 2011 Apr; 60(4):1-86. PubMed ID: 21527890
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid.
Inguva S; Barnard M; Ward LM; Yang Y; Pittman E; Banahan BF; Kirby TR; Noble SL
Vaccine; 2020 Feb; 38(8):2051-2057. PubMed ID: 31980196
[TBL] [Abstract][Full Text] [Related]
8. Personalized Reminders for Immunization Using Short Messaging Systems to Improve Human Papillomavirus Vaccination Series Completion: Parallel-Group Randomized Trial.
Wynn CS; Catallozzi M; Kolff CA; Holleran S; Meyer D; Ramakrishnan R; Stockwell MS
JMIR Mhealth Uhealth; 2021 Dec; 9(12):e26356. PubMed ID: 34958306
[TBL] [Abstract][Full Text] [Related]
9. Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen.
Bednarczyk RA; Brandt HM
Hum Vaccin Immunother; 2023 Dec; 19(1):2204784. PubMed ID: 37138466
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with parental reasons for "no-intent" to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008-2012.
Cheruvu VK; Bhatta MP; Drinkard LN
BMC Pediatr; 2017 Feb; 17(1):52. PubMed ID: 28193249
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with not receiving HPV vaccine among adolescents by metropolitan statistical area status, United States, National Immunization Survey-Teen, 2016-2017.
Williams CL; Walker TY; Elam-Evans LD; Yankey D; Fredua B; Saraiya M; Stokley S
Hum Vaccin Immunother; 2020 Mar; 16(3):562-572. PubMed ID: 31584312
[TBL] [Abstract][Full Text] [Related]
12. Racial/Ethnic and poverty disparities in human papillomavirus vaccination completion.
Niccolai LM; Mehta NR; Hadler JL
Am J Prev Med; 2011 Oct; 41(4):428-33. PubMed ID: 21961471
[TBL] [Abstract][Full Text] [Related]
13. Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial.
Dempsey AF; Pyrznawoski J; Lockhart S; Barnard J; Campagna EJ; Garrett K; Fisher A; Dickinson LM; O'Leary ST
JAMA Pediatr; 2018 May; 172(5):e180016. PubMed ID: 29507952
[TBL] [Abstract][Full Text] [Related]
14. Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.
Adjei Boakye E; Lew D; Muthukrishnan M; Tobo BB; Rohde RL; Varvares MA; Osazuwa-Peters N
Hum Vaccin Immunother; 2018; 14(8):2016-2024. PubMed ID: 29708826
[TBL] [Abstract][Full Text] [Related]
15. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.
Elam-Evans LD; Yankey D; Singleton JA; Sterrett N; Markowitz LE; Williams CL; Fredua B; McNamara L; Stokley S
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(33):1109-1116. PubMed ID: 32817598
[TBL] [Abstract][Full Text] [Related]
16. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study.
Perkins RB; Brogly SB; Adams WG; Freund KM
J Womens Health (Larchmt); 2012 Aug; 21(8):813-20. PubMed ID: 22860770
[TBL] [Abstract][Full Text] [Related]
17. Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series.
Kajtezovic S; Morgan JR; Fiascone S; Brandt HM; Perkins RB
Hum Vaccin Immunother; 2023 Dec; 19(1):2175541. PubMed ID: 36798049
[TBL] [Abstract][Full Text] [Related]
18. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.
Vadaparampil ST; Staras SA; Malo TL; Eddleton KZ; Christie J; Rodriguez M; Giuliano AR; Shenkman EA
Cancer; 2013 Feb; 119(3):621-8. PubMed ID: 23341308
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated with Increased HPV Vaccine Use in Rural-Frontier U.S. States.
Lai D; Ding Q; Bodson J; Warner EL; Kepka D
Public Health Nurs; 2016 Jul; 33(4):283-94. PubMed ID: 26331614
[TBL] [Abstract][Full Text] [Related]
20. Early Initiation of HPV Vaccination and Series Completion in Early and Mid-Adolescence.
Goodman E; Felsher M; Wang D; Yao L; Chen YT
Pediatrics; 2023 Mar; 151(3):. PubMed ID: 36843509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
